Ramesh Shankar, Mumbai Close on the heels of filing four patent challenges in India, two on daclatasvir, one on velpatasvir and another on sofosbuvir, the international NGO– Initiative for Medicines, Access & Knowledge (I-MAK), in association with other NGOs, has…
